mRNA-based melanoma vaccines targeting gp100 and TRP2 macromolecules. - Hosseini Kakroudi M; Rezvanimehr A; Zolfaghari K; Baghaei-Shiva G; Abbasi H; Pourashory M; Yazdanpanah N; Saleki K; Rezaei N (Discover oncology, 2026)